The Hemp Ban Could Slip a Month. Read the Fine Print Before You Celebrate.
Senate leaders released a stopgap that would push most of the federal hemp deadline to December 11. Cannabinoids the plant cannot make […]
Category: Business
Auto Added by WPeMatico
We Legalized Weed… So Why Does It Still Feel Broken?
This article originally appeared in High Times’ Spring/Summer 2026 print edition. Get yours here. Activists, investors, lawyers, growers and a plant scientist […]
Five Years and $100,000 Later, New York Finally Let Me Sell Weed
After five years, two applications, six figures in expenses, and a maze of shifting rules, one New York cannabis entrepreneur finally secured […]
Cannabis Price Wars Are Training Shoppers to Stop Caring
The legal weed business taught customers to chase the next deal, and independent dispensaries are paying the price. Twenty percent off flower. […]
This Cannabis Company Had It Hard for Years. Now It’s in Court to Undo the Reform That Made It Easier for Others.
A drug company spent nearly eight years fighting the DEA to make cannabis medicine the hard way. Now that everyone else is […]
Breaking Down Cannabis Automation’s “Road to Success”
There’s a moment most cannabis operators hit where hustle stops being enough. At first, production is manageable. A few employees can hand-fill […]
The Cannabis Industry Forgot Who Built It
Legal cannabis promised legitimacy. Instead, many of the people who carried the culture through prohibition are being priced, regulated, and pushed out […]
A U.S. Weed Company Finally Cracked The NYSE. It Had To Leave The Recreational Pot Behind.
Trulieve becomes the first U.S. cannabis company to trade on the NYSE on June 10. To get through the door, it carved […]
AI Is Growing Your Weed Now
From robot canopy scanners to algorithmic breeders to AI-powered dispensary counters, artificial intelligence is remaking cannabis at every level. The question nobody […]
Wall Street Is About to Steal Psychedelics From the People Who Need Them
The clinical evidence is real. The valuations are not. Compass Pathways: $560 million market cap, zero revenue. MindMed: up to $2 billion, […]